New drug aims to ease daily struggles of myasthenia gravis
Disease control
Not yet recruiting
This phase 3 trial tests whether claseprubart (DNTH103) can improve symptoms of generalized myasthenia gravis, a condition causing muscle weakness. About 195 adults with a specific antibody type are randomly assigned to receive the drug or a placebo. The main goal is to see if th…
Phase: PHASE3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC